This paper reviews considerations for the formulation of chewable tablets including sensory characteristics, chewability assessment, and drug release.
Nasser N. Nyamweya
Advertisement
Nasser Nyamweya, PhD*, [email protected], is a Director at Pharma Manufacturing Solutions. He was previously a Lecturer at the School of Pharmacy, University of Nairobi.
Articles by Nasser N. Nyamweya
Advertisement
Latest Updated Articles
Chewable Tablets: A Review of Formulation ConsiderationsNovember 2nd 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
2
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
3
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
4
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
5